Modulating BRICHOS for an Alzheimer’s Therapy
Development of CMTM6 inhibitors: Modulation of PDL1 for cancer treatment
FUNctionalized Collagen-based bioink for 3D bioprinting
AD Scanner for Prognosis of Alzheimer’s Disease by Blood Analysis
An on-the-go intra-nasal cooling device for self-treatment of migraine
Development of a sublingual mucosal immunization technology platform for needle-free vaccination
Development of candidate vaccine strains that can be used directly by industry in new cell-based production systems to manufacture influenza vaccines, and the development of a sublingual vaccination route for more efficient vaccination strategies.
The aim of this project is to develop a novel low-cost vaccine against pneumococcal disease that is suitable to be implemented in the emerging markets, using a new vaccine technology that allows intranasal delivery, low-cost vaccine production and broader protection.